Certara

Valuation Analysis

About the Company

Certara en bref

Certara (CERT) is currently trading at 4,83 € with a market capitalization of 752 M €. The 52-week range spans from 3,88 € to 12,11 €; the current price is 60.1% below the yearly high. Year-over-year revenue growth stands at +0.9%.

💰 Dividende

Certara currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

10 analystes évaluent Certara (CERT) au consensus : Acheter. L'objectif de cours moyen est de 6,53 €, soit un potentiel de +35.02% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 5,24 € à 8,73 €.

Certara : la thèse d'investissement en détail

Certara (CERT) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

With a gross margin near 61.59%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Wall Street consensus sits at Buy with an average price target implying roughly 35.02% upside from current levels — analyst sentiment is firmly constructive.

Le scénario baissier

Revenue growth has slowed to just 0.9%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Net margins remain negative, meaning every euro of revenue is still producing losses — the path to profitability is the central question for shareholders. Short interest sits at 28.63% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 35.02% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

The data points to market-like volatility, elevated short interest (28.63%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Certara?

Compare top-rated brokers — low fees, trusted providers, fully regulated.